Pharmaceutical compositions
First Claim
Patent Images
1. A method for treating or preventing pain, and reducing or preventing opioid-induced nausea or vomiting, comprising administering to a subject in need thereof an immediate-release bi-layered tablet, wherein the immediate-release bi-layered tablet comprises:
- a first layer, wherein the first layer comprises;
an antiemetic that is promethazine or a pharmaceutically acceptable salt thereof, and one or more of silicified microcrystalline cellulose, croscarmellose sodium, or magnesium stearate; and
a second layer, wherein the second layer comprises;
an opioid analgesic that is hydrocodone or a pharmaceutically acceptable salt thereof and is not conjugated to a peptide, a non-opioid analgesic that is acetaminophen or a pharmaceutically acceptable salt thereof, and hydroxypropyl methylcellulose,wherein the immediate-release bi-layered tablet provides an effective amount of the opioid analgesic and the non-opioid analgesic to treat or prevent pain in the subject, and wherein the immediate-release bi-layered tablet provides an effective amount of the antiemetic to reduce or prevent nausea associated with the opioid analgesic or reduce or prevent vomiting associated with the opioid analgesic, in the subject.
2 Assignments
0 Petitions
Accused Products
Abstract
Methods and compositions are provided which comprise effective amounts of an analgesic to treat a subject, including reducing or eliminating an adverse effect associated with the analgesic.
-
Citations
30 Claims
-
1. A method for treating or preventing pain, and reducing or preventing opioid-induced nausea or vomiting, comprising administering to a subject in need thereof an immediate-release bi-layered tablet, wherein the immediate-release bi-layered tablet comprises:
-
a first layer, wherein the first layer comprises;
an antiemetic that is promethazine or a pharmaceutically acceptable salt thereof, and one or more of silicified microcrystalline cellulose, croscarmellose sodium, or magnesium stearate; anda second layer, wherein the second layer comprises;
an opioid analgesic that is hydrocodone or a pharmaceutically acceptable salt thereof and is not conjugated to a peptide, a non-opioid analgesic that is acetaminophen or a pharmaceutically acceptable salt thereof, and hydroxypropyl methylcellulose,wherein the immediate-release bi-layered tablet provides an effective amount of the opioid analgesic and the non-opioid analgesic to treat or prevent pain in the subject, and wherein the immediate-release bi-layered tablet provides an effective amount of the antiemetic to reduce or prevent nausea associated with the opioid analgesic or reduce or prevent vomiting associated with the opioid analgesic, in the subject. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 27)
-
-
24. A method for treating or preventing pain, and reducing or preventing opioid-induced nausea or vomiting, comprising administering to a subject in need thereof an immediate-release bi-layered tablet, wherein the immediate-release bi-layered tablet comprises:
-
a first layer, wherein the first layer comprises;
an antiemetic that is promethazine or a pharmaceutically acceptable salt thereof, silicified microcrystalline cellulose, croscarmellose sodium, and magnesium stearate; anda second layer, wherein the second layer comprises;
an opioid analgesic that is hydrocodone or a pharmaceutically acceptable salt thereof and is not conjugated to a peptide, and a non-opioid analgesic that is acetaminophen or a pharmaceutically acceptable salt thereof,wherein the immediate-release bi-layered tablet provides an effective amount of the opioid analgesic and the non-opioid analgesic to treat or prevent pain in the subject, and wherein the immediate-release bi-layered tablet contains an effective amount of the antiemetic to reduce or prevent nausea associated with the opioid analgesic or reduce or prevent vomiting associated with the opioid analgesic, in the subject. - View Dependent Claims (28)
-
-
25. A method for treating or preventing pain, and reducing or preventing opioid-induced nausea or vomiting, comprising administering to a subject in need thereof an immediate-release bi-layered tablet, wherein the immediate-release bi-layered tablet comprises:
-
a first layer, wherein the first layer comprises;
an antiemetic that is promethazine or a pharmaceutically acceptable salt thereof; anda second layer, wherein the second layer comprises;
an opioid analgesic that is hydrocodone or a pharmaceutically acceptable salt thereof and is not conjugated to a peptide, a non-opioid analgesic that is acetaminophen or a pharmaceutically acceptable salt thereof, silicified microcrystalline cellulose, hydroxypropyl methylcellulose, magnesium stearate, and stearic acid,wherein the immediate-release bi-layered tablet provides an effective amount of the opioid analgesic and the non-opioid analgesic to treat or prevent pain in the subject, and wherein the immediate-release bi-layered tablet provides an effective amount of the antiemetic to reduce or prevent nausea associated with the opioid analgesic or reduce or prevent vomiting associated with the opioid analgesic, in the subject. - View Dependent Claims (29)
-
-
26. An immediate-release bi-layered tablet for treatment or prevention of pain, and reduction or prevention of opioid-induced nausea or vomiting, wherein the immediate-release bi-layered tablet comprises:
-
a first layer, wherein the first layer comprises;
an antiemetic that is promethazine or a pharmaceutically acceptable salt thereof, silicified microcrystalline cellulose, croscarmellose sodium, and magnesium stearate; anda second layer, wherein the second layer comprises;
an opioid analgesic that is hydrocodone or a pharmaceutically acceptable salt thereof and is not conjugated to a peptide, a non-opioid analgesic that is acetaminophen or a pharmaceutically acceptable salt thereof, silicified microcrystalline cellulose, hydroxypropyl methylcellulose, magnesium stearate, and stearic acid,wherein the immediate-release bi-layered tablet provides an effective amount of the opioid analgesic and the non-opioid analgesic to treat or prevent pain, and wherein the immediate-release bi-layered tablet contains an effective amount of the antiemetic to reduce or prevent nausea associated with the opioid analgesic or reduce or prevent vomiting associated with the opioid analgesic. - View Dependent Claims (30)
-
Specification